TMED vs. CNCR

Last updated Jun 4, 2026

TMED (T. Rowe Price Health Care ETF) and CNCR (Loncar Cancer Immunotherapy ETF) are both Health & Biotech Equities funds. TMED charges 0.44%/yr vs 0.79%/yr for CNCR.

Performance

TMED vs. CNCR - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in T. Rowe Price Health Care ETF (TMED) and Loncar Cancer Immunotherapy ETF (CNCR). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

TMED

• 1D: 1.04%
• 1M: 2.47%
• YTD: 3.87%
• 6M: 4.17%
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

CNCR

• 1D: 0.00%
• 1M: 0.00%
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

TMED vs. CNCR - Yearly Performance Comparison

	2026 (YTD)
TMED T. Rowe Price Health Care ETF	4.20%
CNCR Loncar Cancer Immunotherapy ETF	0.00%

Return for Risk

TMED vs. CNCR - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for T. Rowe Price Health Care ETF (TMED) and Loncar Cancer Immunotherapy ETF (CNCR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

Sharpe Ratios by Period

	TMED	CNCR	Difference
Sharpe Ratio (All Time) Calculated using the full available price history	1.35	—	—

Drawdowns

TMED vs. CNCR - Drawdown Comparison

The maximum TMED drawdown since its inception was -11.11%, which is greater than CNCR's maximum drawdown of 0.00%. Use the drawdown chart below to compare losses from any high point for TMED and CNCR.

Drawdown Indicators

	TMED	CNCR	Difference
Max Drawdown Largest peak-to-trough decline	-11.11%	0.00%	-11.11%
Current Drawdown Current decline from peak	-2.75%	0.00%	-2.75%
Average Drawdown Average peak-to-trough decline	-2.59%	0.00%	-2.59%

Volatility

Volatility by Period

	TMED	CNCR	Difference
Volatility (1Y) Calculated over the trailing 1-year period	18.04%	0.00%	+18.04%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	18.04%	0.00%	+18.04%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	18.04%	0.00%	+18.04%

TMED vs. CNCR - Expense Ratio Comparison

TMED has a 0.44% expense ratio, which is lower than CNCR's 0.79% expense ratio.

Dividends

TMED vs. CNCR - Dividend Comparison

TMED's dividend yield for the trailing twelve months is around 0.52%, while CNCR has not paid dividends to shareholders.

Position	TTM	2025
CNCR Loncar Cancer Immunotherapy ETF	0.00%	0.00%
TMED T. Rowe Price Health Care ETF	0.52%	0.54%

Frequently Asked Questions

Which ETF is better, TMED or CNCR?

On fees, TMED is cheaper at 0.44% per year. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF is cheaper, TMED or CNCR?

TMED is cheaper with a 0.44% expense ratio, compared with 0.79% for CNCR.

Which ETF pays a higher dividend yield, TMED or CNCR?

TMED has the higher dividend yield at 0.52%, compared with 0.00% for CNCR.

What is the main difference between TMED and CNCR?

They also come from different issuers: T. Rowe Price and Exchange Traded Concepts. Their fees differ too: 0.44% for TMED and 0.79% for CNCR.